Diehm Nicolas, Dick Florian, Katzen Barry T, Do Dai-Do, Baumgartner Iris
Clinical and Interventional Angiology, Swiss Cardiovascular Center, Inselspital, University Hospital Bern, Switzerland.
J Endovasc Ther. 2009 Feb;16 Suppl 1:I119-26. doi: 10.1583/08-2586.1.
Endovascular aneurysm repair has matured significantly over the last 20 years and is becoming increasingly popular as a minimally invasive treatment option for patients with abdominal aortic aneurysms (AAA). Long-term durability of this fascinating treatment, however, is in doubt as continuing aneurysmal degeneration of the aortoiliac graft attachment zones is clearly associated with late adverse sequelae. In recent years, our growing understanding of the physiopathology of AAA formation has facilitated scrutiny of various potential drug treatment concepts. In this article we review the mechanical and biological challenges associated with endovascular treatment of infrarenal AAAs and discuss potential approaches to ongoing aneurysmal degeneration, which hampers long-term outcomes of this minimally invasive therapy.
在过去20年中,血管内动脉瘤修复术已显著成熟,作为腹主动脉瘤(AAA)患者的一种微创治疗选择,其越来越受欢迎。然而,这种引人注目的治疗方法的长期耐久性受到质疑,因为主动脉髂动脉移植物附着区持续的动脉瘤退变显然与晚期不良后遗症相关。近年来,我们对AAA形成的生理病理学的不断了解促进了对各种潜在药物治疗概念的审视。在本文中,我们回顾了与肾下腹主动脉瘤血管内治疗相关的机械和生物学挑战,并讨论了针对持续的动脉瘤退变的潜在方法,这种退变阻碍了这种微创治疗的长期效果。